HomeCompareAIVEX vs JNJ

AIVEX vs JNJ: Dividend Comparison 2026

AIVEX yields 3.20% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AIVEX wins by $4.5K in total portfolio value
10 years
AIVEX
AIVEX
● Live price
3.20%
Share price
$19.60
Annual div
$0.63
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.6K
Annual income
$393.44
Full AIVEX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — AIVEX vs JNJ

📍 AIVEX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAIVEXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AIVEX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AIVEX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AIVEX
Annual income on $10K today (after 15% tax)
$272.13/yr
After 10yr DRIP, annual income (after tax)
$334.42/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $369.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AIVEX + JNJ for your $10,000?

AIVEX: 50%JNJ: 50%
100% JNJ50/50100% AIVEX
Portfolio after 10yr
$22.3K
Annual income
$610.61/yr
Blended yield
2.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AIVEX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AIVEX buys
0
JNJ buys
0
No recent congressional trades found for AIVEX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAIVEXJNJ
Forward yield3.20%3.36%
Annual dividend / share$0.63$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$24.6K$20.0K
Annual income after 10y$393.44$827.78
Total dividends collected$3.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AIVEX vs JNJ ($10,000, DRIP)

YearAIVEX PortfolioAIVEX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,020$320.15$10,676$355.77+$344.00AIVEX
2$12,121$329.73$11,407$389.39+$714.00AIVEX
3$13,309$338.95$12,198$426.53+$1.1KAIVEX
4$14,588$347.81$13,056$467.62+$1.5KAIVEX
5$15,966$356.31$13,987$513.12+$2.0KAIVEX
6$17,448$364.44$14,998$563.56+$2.5KAIVEX
7$19,041$372.21$16,098$619.52+$2.9KAIVEX
8$20,754$379.63$17,295$681.69+$3.5KAIVEX
9$22,593$386.71$18,599$750.82+$4.0KAIVEX
10$24,568$393.44$20,022$827.78+$4.5KAIVEX

AIVEX vs JNJ: Complete Analysis 2026

AIVEXStock

The fund invests primarily in common stocks of issuers outside of the United States that the investment adviser believes have the potential for growth, many of which have the potential to pay dividends. Under normal market conditions, it invests at least 80% of its net assets in equity-type securities and at least 80% of its net assets in securities of issuers outside the United States. The fund may invest up to 10% of its net assets in the securities of issuers based in emerging markets.

Full AIVEX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this AIVEX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AIVEX vs SCHDAIVEX vs JEPIAIVEX vs OAIVEX vs KOAIVEX vs MAINAIVEX vs ABBVAIVEX vs MRKAIVEX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.